Posted by Michael Wonder on 31 Aug 2016
TGA approves Zepatier
31 August 2016 - The TGA has approved MSD's Zepatier (grazoprevir with elbasvir).
The TGA approved Zepatier on 29 August 2016 for the treatment of chronic hepatitis C genotype 1 or 4 infection in adults.
